NCT01637922View on ClinicalTrials.gov

Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Hepatitis C
Interventions
DRUG

BI 201335

BI 201335 for 9 days

DRUG

BI 201335

BI 201335 for 9 days

Trial Locations (3)

Unknown

1220.57.0001 Boehringer Ingelheim Investigational Site, Atlanta

1220.57.0002 Boehringer Ingelheim Investigational Site, Overland Park

1220.57.0003 Boehringer Ingelheim Investigational Site, Salt Lake City

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01637922 - Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone | Biotech Hunter | Biotech Hunter